Delivery Order SPE2DB24D9248-SPE2DB24FGRCQ

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,317.08, is for the delivery of PREVNAR 20 syringes (0.5 mL) to support the medical supply needs of military health facilities. This contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $177,236.00 order is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal conjugate vaccine, with a period of performance through July 10, 2024. The award is issued against a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This is a $3,544.74 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Prevnar 20 syringe 0.5 ML to support the recurring medical supply needs of military health facilities. It is associated with a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,447.20, is for the delivery of Prevnar 20 syringes. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,089.44, is for the delivery of PREVNAR 20 SYRINGE 0.5ML to support the recurring medical supply needs of military health facilities. This order is issued under a larger single-award indefinite delivery contract (IDC), valued at up to $499,999,999, that DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,544.44 contract is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal vaccine product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of July 10, 2024 and is not associated with any set-aside designation....
This is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,544.74 firm fixed-price contract is for the delivery of PREVNAR 20 (pneumococcal conjugate vaccine) syringes to support the medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA....
This is a firm fixed-price delivery order worth $8,861.80 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of Prevnar 20, a pneumococcal vaccine, and is a task order against DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PREVNAR 20 SYRINGE 0.5ML, a specialized pharmaceutical product, with a ceiling value of $17,722.20 and a completion date of July 9, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PREVNAR 20 Syringe 0.5ML, a pharmaceutical product, and has a ceiling value of $7,088.88. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB24D9248
    Indefinite Delivery Contract
  • SPE2DB24D9248-SPE2DB24FGRCQ
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,772.36, is for the delivery of PREVNAR 20 vaccine syringes (0.5 mL) to support the recurring medical supply needs of military health facilities.

DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including both common medications and specialized drugs, to fulfill the diverse medical requirements of Department of Defense (DoD) healthcare facilities worldwide. This contract does not have a set-aside designation.

Generated 10/23/24, 9:27 AM